| Code | 2543F | ||||||||||
| MA number | 07/0037/26-S | ||||||||||
| Product Form: | tbl eff 10x400 mg/240 mg (tuba PP) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Dr. Max Pharma s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 07 - ANALGETICA, ANTIPYRETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | tube polypropylene | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 13.02.2026 |
| Validity: | 13.02.2031 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Algirin Plus_02 2026.pdf
|
| SPC: |
SPC_Algirin Plus_02.2026.pdf
|
| Safety feature | No |
| Data update: | 23.02.2026 |
